Anne Hathaway showed her support during a recent evening with The Bachmann-Strauss Dystonia & Parkinson Foundation where she addressed her role as a Parkinson’s patient in her new film “Love & Other Drugs.” The Bachmann-Strauss Foundation invited their generous supporters to join Anne Hathaway over an intimate dinner at Il Postino, followed by a screening of her movie at The Japan Society. Anne introduced the film by speaking about her experience playing the character of Maggie, the importance of bringing awareness to both Parkinson’s disease and dystonia and how proud she is to be involved with The Bachmann-Strauss Dystonia & Parkinson Foundation.
In this emotional comedy, Anne Hathaway portrays Maggie, an alluring free spirit who won’t let anything, including a formidable personal challenge, tie her down. But she meets her match in Jamie (Jake Gyllenhaal), whose relentless and nearly infallible charm serve him well with women and in the cutthroat world of pharmaceutical sales. Maggie and Jamie’s evolving relationship takes them both by surprise, as they find themselves under the influence of the ultimate drug: love. Most relationships proceed from love to sex. This one goes the opposite direction and thus makes an unexpected film from an unconventional love story.
The Bachmann-Strauss Dystonia & Parkinson Foundation is the leading organization actively looking at the connection between dystonia & Parkinson’s disease, which impact the lives of over 1.5 million people in the United States. Fifteen years ago, determined to find answers to her movement disorder condition called dystonia, Founder and President, Bonnie Strauss, set out to raise awareness and the need for funding cure-focused research. The Foundation has blossomed into one that raises millions of dollars for scientific research and remains the only organization studying the overlap between Parkinson's and dystonia (40% of Parkinson’s patients have dystonia). Its strategic investments include awarding “seed money” to scientists enabling them to explore their most promising hypotheses and leverage additional funding.
For more information visit: www.dystonia-parkinson.org
Comments